Career records & work history
Lawyers & Attorneys
James F. Mongoven - Lawyer
Licenses:
New York - Currently registered 1981
Education:
Columbia University School of Law
James W Mongoven, 66Hoffman Estates, IL
James Mongoven Phones & Addresses
Long Grove, IL
7017 Rfd, Long Grove, IL 60060 847-5661950
Lake Zurich, IL
Grayslake, IL
Buffalo Grove, IL
Social networks
James W Mongoven
Linkedin
Education
School / High School:
Columbia University School of Law
Ranks
Licence:
New York - Currently registered
Date:
1981
Mentions for James W Mongoven
James Mongoven resumes & CV records
Resumes
James Mongoven
Publications & IP owners
Us Patents
Methods And Compositions For Detection Of Microbial Contaminants In Peritoneal Dialysis Solution
US Patent:
7618392, Nov 17, 2009
Filed:
Jul 13, 2006
Appl. No.:
11/457330
Inventors:
Leo Martis - Long Grove IL, US
Mehul Patel - Sauderstown RI, US
Joseph A. Giertych - Lake Forest IL, US
James W. Mongoven - Long Grove IL, US
Jacqueline A. Kunzler - Downers Grove IL, US
Mehul Patel - Sauderstown RI, US
Joseph A. Giertych - Lake Forest IL, US
James W. Mongoven - Long Grove IL, US
Jacqueline A. Kunzler - Downers Grove IL, US
Assignee:
Baxter International Inc. - Deerfield IL
Baxter Healthcare S.A. - Zurich
Baxter Healthcare S.A. - Zurich
International Classification:
C12Q 1/00
US Classification:
604 29, 604 28, 435 4, 435 14, 435 29, 435 34, 436 1, 436815, 422 1
Abstract:
Methods and compositions for detection of microbial contaminants in peritoneal dialysis solutions are provided. The methods and compositions employ modified bioburden testing and the detection of peptidoglycan. A novel cause of aseptic peritonitis is provided—aseptic peritonitis associated with gram positive microbial contamination of a dialysis solution. Peptidoglycan is a major component of a gram positive bacterial cell wall and thus can serve as a marker for gram positive bacteria. In this regard, testing for peptidoglycans can be utilized to effectively prevent peritonitis in patients that use the peritoneal dialysis solutions, such as peritoneal dialysis solutions that contain a glucose polymer including an icodextrin and the like.
Methods And Compositions For Detection Of Microbial Contaminants In Peritoneal Dialysis Solutions
US Patent:
8546097, Oct 1, 2013
Filed:
Nov 13, 2009
Appl. No.:
12/618442
Inventors:
Leo Martis - Long Grove IL, US
Mehul Patel - Saunderstown RI, US
Joseph A. Giertych - Lake Forest IL, US
James W. Mongoven - Long Grove IL, US
Jacqueline A. Kunzler - Downers Grove IL, US
Mehul Patel - Saunderstown RI, US
Joseph A. Giertych - Lake Forest IL, US
James W. Mongoven - Long Grove IL, US
Jacqueline A. Kunzler - Downers Grove IL, US
Assignee:
Baxter International Inc. - Deerfield IL
Baxter Healthcare S.A. - Glattpark (Opfikon)
Baxter Healthcare S.A. - Glattpark (Opfikon)
International Classification:
C12G 1/00
US Classification:
435 14, 435 4, 435 31, 435 39, 436 1, 436815, 422 1, 604 29
Abstract:
Methods and compositions for detection of microbial contaminants in peritoneal dialysis solutions are provided. The methods and compositions employ modified bioburden testing and the detection of peptidoglycan. A novel cause of aseptic peritonitis is provided—aseptic peritonitis associated with gram positive microbial contamination of a dialysis solution. Peptidoglycan is a major component of a gram positive bacterial cell wall and thus can serve as a marker for gram positive bacteria. In this regard, testing for peptidoglycans can be utilized to effectively prevent peritonitis in patients that use the peritoneal dialysis solutions, such as peritoneal dialysis solutions that contain a glucose polymer including an icodextrin and the like.
Methods And Compositions For Detection Of Microbial Contaminants In Peritoneal Dialysis Solutions
US Patent:
2005019, Sep 1, 2005
Filed:
Feb 27, 2004
Appl. No.:
10/789320
Inventors:
Leo Martis - Long Grove IL, US
Mehul Patel - Sauderstown RI, US
Joseph Giertych - Lake Forest IL, US
James Mongoven - Long Grove IL, US
Jacqueline Kunzler - Downers Grove IL, US
William Owen - Durham NC, US
Mehul Patel - Sauderstown RI, US
Joseph Giertych - Lake Forest IL, US
James Mongoven - Long Grove IL, US
Jacqueline Kunzler - Downers Grove IL, US
William Owen - Durham NC, US
International Classification:
C12Q001/54
C12Q001/37
A61K031/715
C12Q001/37
A61K031/715
US Classification:
435014000, 514054000
Abstract:
Methods and compositions for detection of microbial contaminants in peritoneal dialysis solutions are provided. The methods and compositions employ modified bioburden testing and the detection of peptidoglycan. A novel cause of aseptic peritonitis is provided—aseptic peritonitis associated with gram positive microbial contamination of a dialysis solution. Peptidoglycan is a major component of a gram positive bacterial cell wall and thus can serve as a marker for gram positive bacteria. In this regard, testing for peptidoglycans can be utilized to effectively prevent peritonitis in patients that use the peritoneal dialysis solutions, such as peritoneal dialysis solutions that contain a glucose polymer including an icodextrin and the like.
Methods And Compositions For Detection Of Microbial Contaminants In Peritoneal Dialysis Solutions
US Patent:
2013033, Dec 19, 2013
Filed:
Aug 23, 2013
Appl. No.:
13/974872
Inventors:
- Glattpark (Opfikon), CH
Joseph A. Giertych - Lake Forest IL, US
James W. Mongoven - Long Grove IL, US
Jacqueline A. Kunzier - Downers Grove IL, US
William F. Owen - Durham NC, US
Joseph A. Giertych - Lake Forest IL, US
James W. Mongoven - Long Grove IL, US
Jacqueline A. Kunzier - Downers Grove IL, US
William F. Owen - Durham NC, US
Assignee:
Baxter International Inc. - Deerfield IL
International Classification:
A61K 31/716
US Classification:
514 54
Abstract:
Methods and compositions for detection of microbial contaminants in peritoneal dialysis solutions are provided. A novel cause of aseptic peritonitis is provided—aseptic peritonitis associated with gram positive microbial contamination of a dialysis solution. Peptidoglycan is a major component of a gram positive bacterial cell wall and thus can serve as a marker for gram positive bacteria. In this regard, testing for peptidoglycans can be utilized to effectively prevent peritonitis in patients that use the peritoneal dialysis solutions, such as peritoneal dialysis solutions that contain a glucose polymer including an icodextrin and the like.
NOTICE: You may not use BackgroundCheck or the information it provides to make decisions about employment, credit, housing or any other purpose that would require Fair Credit Reporting Act (FCRA) compliance. BackgroundCheck is not a Consumer Reporting Agency (CRA) as defined by the FCRA and does not provide consumer reports.